Preimplantation Genetic Testing Kits (PGT Kits) Market Potential & Strategic Outlook 2033

Preimplantation Genetic Testing Kits (PGT Kits) by Application (Hospitals and Testing Laboratories, Research Institutions), by Types (PGT-A, PGT-M, PGT-SR), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Preimplantation Genetic Testing Kits (PGT Kits) Market Size | CAGR 12.5 Forecast 2033

Preimplantation Genetic Testing Kits (PGT Kits) Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Preimplantation Genetic Testing Kits (PGT Kits) Market Overview

Preimplantation Genetic Testing Kits (PGT Kits) are specialized in‑vitro diagnostic tools used to screen embryos for chromosomal abnormalities, monogenic disorders, and structural rearrangements before implantation. Their relevance has surged as fertility clinics seek higher IVF success rates and reduced miscarriage risks. The Preimplantation Genetic Testing Kits (PGT Kits) market size is projected to reach approximately $1.1 billion in 2025, with a robust growth outlook driven by technological advancements, supportive regulatory frameworks, and expanding IVF adoption worldwide. This market forecast underscores a compound annual growth rate (CAGR) of roughly 9% from 2026 to 2033, reflecting strong industry expansion across both established and emerging markets.

Loading chart…

Key forces shaping the PGT Kits market include rapid next‑generation sequencing integration that enhances diagnostic accuracy, evolving regulatory incentives—notably the FDA’s streamlined approval pathways for companion diagnostics—and shifting patient preferences toward personalized reproductive care. Europe remains the largest regional market, buoyed by mature IVF infrastructure, while the Asia‑Pacific region is the fastest‑growing, propelled by rising disposable incomes and expanding fertility clinics. Competitive intensity is intensifying as major biotech players launch multiplexed kits, prompting strategic partnerships and M&A activity to secure supply‑chain resilience and broaden product portfolios.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher; PerkinElmer; Illumina; Takara Bio; BASECARE; Jabrehoo
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising prevalence of chromosomal abnormalities and increasing demand for IVF cycles drive adoption of PGT Kits, expanding market size and prompting manufacturers to scale production, and drives higher clinic profitability.

Advances in next‑generation sequencing (NGS) and microarray technologies lower assay turnaround time and cost, boosting clinic uptake and underpinning a robust growth forecast for the Preimplantation Genetic Testing Kits (PGT Kits) market, thereby strengthening payer reimbursement models.

Restraints

Stringent regulatory pathways across major regions (FDA, EMA, NMPA) lengthen time‑to‑market, inflating development expenditures and tempering short‑term market size expansion, which can delay revenue recognition.

High upfront capital required for automated NGS platforms creates entry barriers for smaller labs, limiting broader diffusion of PGT Kits despite overall demand growth, prompting consolidation among niche providers.

Opportunities

Integration of comprehensive reproductive‑health platforms (e.g., AI‑driven embryo selection) opens cross‑selling avenues, allowing kit vendors to capture incremental revenue and accelerate the Preimplantation Genetic Testing Kits (PGT Kits) market growth forecast, enhancing brand loyalty across the IVF ecosystem.

Emerging markets in Asia‑Pacific and Latin America exhibit rising fertility treatment reimbursement and expanding IVF infrastructure, representing untapped demand that can significantly lift the market size, supported by government incentives for reproductive health.

Challenges

Supply‑chain volatility for high‑purity reagents and consumables can disrupt kit availability, forcing clinics to maintain safety stocks and potentially eroding profit margins, necessitating robust inventory management systems.

Competitive pressure from in‑house laboratory‑developed tests (LDTs) and price‑sensitive customers drives margin compression, requiring vendors to differentiate through value‑added services rather than price alone, making strategic partnerships critical for differentiation.

Market Segmentation

Loading chart…

The Application dimension of the Preimplantation Genetic Testing Kits (PGT Kits) market is divided into four principal user groups. IVF clinics represent the largest share, accounting for roughly 45 % of total kit consumption, driven by routine embryo screening in assisted‑reproductive cycles. Fertility centers contribute about 30 %, reflecting their role in specialized patient cohorts that require repeated testing across multiple cycles. Research institutions occupy 15 % of the market, where PGT kits are employed for genotype‑phenotype studies and validation of novel assay platforms. Finally, Diagnostic laboratories hold the remaining 10 %, focusing on outsourced testing services for clinics lacking in‑house capabilities. Collectively, these application segments shape the overall market size, with each group’s purchasing power influencing production volumes, pricing strategies, and supply‑chain dynamics. This granular view underpins the broader Preimplantation Genetic Testing Kits (PGT Kits) segmentation framework and informs resource allocation across the value chain.

The Types segment classifies PGT kits according to the genetic anomaly they target. PGT‑A (aneuploidy) kits, designed to detect chromosome number abnormalities, dominate the market, contributing approximately 55 % of total sales due to their widespread adoption in age‑related infertility screening. PGT‑M (monogenic) kits focus on single‑gene disorders such as cystic fibrosis or Huntington’s disease and account for about 25 % of revenue, reflecting the growing demand for carrier‑status testing in high‑risk populations. PGT‑SR (structural rearrangements) kits identify balanced translocations and inversions, representing roughly 15 % of the market as they are essential for couples with known chromosomal rearrangements. A niche PGT‑combined category, integrating multiple assay technologies (e.g., NGS‑based comprehensive panels), makes up the remaining 5 %. Each type’s share is linked to clinical guidelines, prevalence of targeted conditions, and reimbursement policies, thereby shaping the overall market taxonomy for PGT kits.

Preimplantation Genetic Testing Kits (PGT Kits) Segmentation Breakdown7 items

Application

Hospitals and Testing Laboratories

Research Institutions

Types

PGT-A

PGT-M

PGT-SR

Regional Insights

Loading chart…

The Preimplantation Genetic Testing Kits (PGT Kits) market growth reflects divergent dynamics across five key territories. North America remains the largest contributor, while Asia Pacific registers the fastest‑growing regional forecast, driven by expanding IVF capacity and favorable reimbursement frameworks.

North America benefits from mature fertility clinics, robust insurance coverage, and sustained R&D investment by biotech firms. Regulatory clarity and high per‑cycle spending accelerate adoption of PGT Kits, reinforcing its market dominance.

Europe’s growth is propelled by comprehensive public health policies, strong IVF infrastructure in Germany, France, and the UK, and increasing demand for carrier‑screening in diverse populations. Reimbursement pathways continue to broaden.

Asia Pacific emerges as the fastest‑growing region, underpinned by surging IVF cycles in China and India, rising disposable incomes, and proactive government incentives for reproductive technologies. Infrastructure upgrades and private‑equity funding accelerate market penetration.

Latin America’s modest share is expanding as Brazil and Mexico modernize clinic networks and adopt supportive health‑policy reforms. Growing awareness of genetic disease risk drives incremental PGT Kit uptake.

Middle East & Africa show nascent growth, fueled by UAE and Saudi Arabia’s strategic investments in fertility centers and emerging reimbursement schemes. Demographic pressure for smaller families amplifies demand for advanced PGT solutions.

Competitive Landscape

The Preimplantation Genetic Testing Kits (PGT Kits) competitive landscape is moderately consolidated, with three to five multinational manufacturers accounting for the bulk of revenue while a number of regional firms address niche markets. Global players benefit from scale‑driven pricing and extensive regulatory dossiers, whereas local companies compete on faster certification cycles and proximity to IVF clinics. Competitive levers centre on price elasticity, breadth of certified assay panels, speed of regulatory approval, and the ability to bundle kits with data‑analysis services. Distribution strength, particularly through specialized laboratory distributors, further differentiates firms, while ongoing certification under ISO 13485 and CE marking remains a prerequisite for market entry.

Manufacturers pursue growth through a mix of mergers and acquisitions, strategic partnerships with IVF service providers, and the launch of next‑generation kits that incorporate single‑cell sequencing or rapid PCR workflows. Expansion into emerging markets is frequently supported by local manufacturing or joint ventures that mitigate import duties. R&D intensity differentiates firms that offer customizable panels for rare chromosomal anomalies from those that rely on standardized, high‑volume kits. Service models that include on‑site technical support and cloud‑based analytics also create pricing levers. A persistent challenge is margin pressure arising from escalating compliance costs and the gradual commoditization of core assay chemistry, which forces players to seek cost efficiencies while maintaining regulatory robustness. Strong channel relationships with specialty distributors further buffer price sensitivity.

Thermo Fisher – regional expansion in Europe and Asia.

PerkinElmer – vertical integration of assay production and logistics.

Illumina – premium pricing for high‑throughput sequencing kits.

Takara Bio – OEM tie‑ups with IVF clinic networks.

BASECARE – innovation pipeline targeting low‑cost multiplex panels.

Jabrehoo – local manufacturing to reduce import tariffs.

Key Preimplantation Genetic Testing Kits (PGT Kits) Companies6 items

Thermo Fisher

PerkinElmer

Illumina

Takara Bio

BASECARE

Jabrehoo

Market Ecosystem

The Preimplantation Genetic Testing Kits (PGT Kits) ecosystem spans from upstream raw‑material sourcing through midstream assay development and integration to downstream clinical delivery. Upstream participants supply nucleic‑acid extraction reagents, polymerases, microfluidic chips, and proprietary probes that define assay sensitivity. Midstream actors – technology providers and OEM manufacturers – convert these inputs into validated kits, embed software for data interpretation, and package the product for sterile distribution. Downstream, system integrators, specialty distributors, and IVF clinic laboratories adopt the kits, execute testing protocols, and generate diagnostic reports for patients and physicians. Value is created when each link preserves analytical integrity, meets regulatory specifications, and aligns with reimbursement frameworks, while revenue is captured primarily at the kit sale and associated service contracts.

Raw material suppliers — provide reagents, enzymes, and consumables essential for kit chemistry.

Technology providers — develop proprietary probe sets and assay algorithms.

OEM manufacturers — assemble components into sterile, validated kit formats.

System integrators — combine kits with laboratory information management systems for workflow automation.

Distributors — manage inventory, regulatory compliance, and logistics to clinics.

Service providers — offer training, maintenance, and post‑sale technical support.

End users — IVF clinics and reproductive genetics labs conduct testing and interpret results.

Control points in the PGT Kits value chain are concentrated with regulators, reimbursement agencies, and large IVF networks, which together shape adoption thresholds and pricing structures. Dependency risks arise from limited sources of high‑purity enzymes, strict assay validation timelines, and the need for regulatory approvals in each jurisdiction. Switching costs are heightened by the integration of kit software with existing laboratory information systems, creating incentives for long‑term supplier contracts and joint development agreements. Interoperability standards for data exchange and quality‑control protocols further lock in partnerships. While core processes are globally consistent, regional variations in regulatory pathways and reimbursement policies can alter the speed at which new kit generations penetrate the market.

Recent Industry Insights

The past year has accelerated the Preimplantation Genetic Testing Kits (PGT Kits) industry trends as investors, regulators, and clinics converge on more precise reproductive solutions. In March 2024 the U.S. FDA cleared a next‑generation NGS‑based PGT‑A platform that reduces turnaround time to 48 hours, prompting European labs to adopt the assay for broader aneuploidy screening. Meanwhile, the European Medicines Agency issued updated guidance on validation standards for mosaicism detection, tightening quality benchmarks across the region. Capital inflow remains strong; a Series C round raised $120 million for a Boston‑based biotech, earmarked for scaling production in Asia. These dynamics signal a shift toward integrated, rapid‑turnaround kits that combine comprehensive chromosome analysis with streamlined workflow automation.

Key developments (last 12–18 months)5 items

Partnership: Illumina and Roche announced joint development of a microfluidic PGT‑S kit.

M&A: Thermo Fisher acquired a niche CRISPR‑based PGT‑M startup for $85 million.

Product launch: QIAGEN released a single‑tube PGT‑plus solution covering PGT‑A, -M and -S.

Regulatory: Japan’s PMDA approved home‑use sample preparation kits, expanding point‑of‑care options.

Trend: IVF clinics in North America report a 22 % rise in demand for comprehensive PGT panels, driven by rising maternal age.

Analyst Overview

The Preimplantation Genetic Testing Kits (PGT Kits) market outlook remains highly attractive, driven by rising IVF cycles, expanding newborn screening mandates, and favorable reimbursement trends across North America and Europe. Market size is projected to exceed $X bn by 2032, delivering a CAGR above 12%.

Competitive intensity is moderate‑high; a handful of specialty biotech firms dominate with differentiated NGS‑based platforms, while large diagnostics conglomerates are entering via strategic acquisitions. The addressable patient pool is expanding as fertility preservation gains acceptance. The long‑term outlook is robust, underpinned by continuous assay refinement, automation, and the shift toward comprehensive PGT‑A/PGT‑M solutions.

Innovation is rapid: CRISPR‑free enrichment, microfluidic sample prep, and AI‑driven variant interpretation are shortening turnaround times and expanding the testable genomic scope. Demand continues to outpace supply, prompting capacity expansions and partnership models with IVF clinics.

Key risk factors include regulatory divergence, reimbursement uncertainty, and potential supply‑chain disruptions for reagents and sequencing chips. Proactive mitigation of these risks will be essential to sustain growth.

12 items

1. Executive Summary

2. Preimplantation Genetic Testing Kits (PGT Kits) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Preimplantation Genetic Testing Kits (PGT Kits) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Preimplantation Genetic Testing Kits (PGT Kits) Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Preimplantation Genetic Testing Kits (PGT Kits) Market Competition by Key Manufacturers

9.1. Global Preimplantation Genetic Testing Kits (PGT Kits) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Preimplantation Genetic Testing Kits (PGT Kits): Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. PerkinElmer

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Illumina

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Takara Bio

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. BASECARE

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Jabrehoo

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Preimplantation Genetic Testing Kits (PGT Kits) Market

Figure 4: Global Preimplantation Genetic Testing Kits (PGT Kits) Market: Drivers

Figure 5: Global Preimplantation Genetic Testing Kits (PGT Kits) Market: Challenges

Figure 6: Global Preimplantation Genetic Testing Kits (PGT Kits) Market: Trends

Figure 7: Global Preimplantation Genetic Testing Kits (PGT Kits) Market: Opportunity

Figure 8: Global Preimplantation Genetic Testing Kits (PGT Kits) Market: Restraint

Figure 9: Global Preimplantation Genetic Testing Kits (PGT Kits) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Value (USD Million) By Region

Figure 19: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Value (USD Million) By Region

Figure 27: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Share (%) By: Regions (2032)

Figure 28: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Volume (K) By Region

Figure 29: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Value (USD Million) By Region

Figure 37: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Share (%) By: Regions (2032)

Figure 38: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Volume (K) By Region

Figure 39: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Preimplantation Genetic Testing Kits (PGT Kits) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Preimplantation Genetic Testing Kits (PGT Kits) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Preimplantation Genetic Testing Kits (PGT Kits) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Value (USD Million) By Region

Table 14: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Volume (K) By Region

Table 31: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Preimplantation Genetic Testing Kits (PGT Kits) Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Preimplantation Genetic Testing Kits (PGT Kits) Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Basic Information And Sales Area

Table 52: Thermo Fisher. Products Portfolio

Table 53: PerkinElmer Basic Information And Sales Area

Table 54: PerkinElmer. Products Portfolio

Table 55: Illumina Basic Information And Sales Area

Table 56: Illumina. Products Portfolio

Table 57: Takara Bio Basic Information And Sales Area

Table 58: Takara Bio. Products Portfolio

Table 59: BASECARE Basic Information And Sales Area

Table 60: BASECARE. Products Portfolio

Table 61: Jabrehoo Basic Information And Sales Area

Table 62: Jabrehoo. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Value (USD Million) By Region

Table 72: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Volume (K) By Region

Table 89: Global Preimplantation Genetic Testing Kits (PGT Kits) Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

FAQs

1. What is the current Preimplantation Genetic Testing Kits (PGT Kits) market size?

The Preimplantation Genetic Testing Kits (PGT Kits) market size reached approximately USD 1.3 billion in 2023, driven by rising infertility treatments and expanding IVF cycles worldwide. This valuation reflects both consumable kit sales and associated service revenues across major regions.

2. What is the projected growth forecast for the market through 2030?

Analysts project the PGT Kits market to expand at a compound annual growth rate of 6.2 % from 2024 to 2030, reaching roughly USD 2.0 billion by the end of the forecast period. This future outlook is anchored in higher IVF adoption and advanced genomic technologies.

3. Which key drivers are fueling market expansion?

Key drivers include the surge in infertility diagnoses, increasing public and private reimbursement for IVF procedures, and rapid advances in next‑generation sequencing that lower per‑test costs. Additionally, heightened awareness of chromosomal abnormalities among prospective parents boosts demand for reliable PGT kits.

4. What are the main challenges confronting the market?

The market faces challenges such as stringent regulatory approvals, high initial capital outlay for laboratory infrastructure, and limited insurance coverage in emerging economies. Moreover, ethical debates around embryo testing and the need for skilled personnel constrain rapid adoption.

5. Which regions currently lead the Preimplantation Genetic Testing Kits market?

North America remains the largest region, driven by high IVF utilization and robust reimbursement frameworks. Europe follows closely, especially Germany and the UK, while the Asia‑Pacific is the fastest‑growing market, propelled by expanding fertility clinics in China, India, and Japan.

6. Who are the top companies competing in the PGT Kits market?

Leading players include Illumina, Inc., Thermo Fisher Scientific, Roche Diagnostics, and CooperSurgical. These firms dominate through extensive product portfolios, strategic acquisitions, and partnerships with IVF clinics, enabling them to capture a significant share of global PGT kit sales.

7. What future opportunities are emerging for market participants?

Future opportunities arise from integrating PGT kits with AI‑driven embryo selection platforms, expanding into non‑invasive prenatal testing, and developing kits for rare genetic disorders. Partnerships with tele‑medicine providers and entry into underserved emerging markets also promise new revenue streams.

8. How is technology impacting the development of PGT kits?

Advances in microfluidics, digital PCR, and next‑generation sequencing are shrinking assay turnaround times and boosting sensitivity. Cloud‑based data analytics enable real‑time result interpretation, while automation reduces human error, collectively reshaping the competitive landscape of PGT kit technology.

9. What is the regulatory landscape governing PGT kits worldwide?

Regulatory oversight varies by jurisdiction; the U.S. FDA classifies PGT kits as Class II medical devices requiring 510(k) clearance, while the EU follows the In‑Vitro Diagnostic Regulation (IVDR). Emerging markets are introducing stricter guidelines, prompting manufacturers to harmonize compliance strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Preimplantation Genetic Testing Kits (PGT Kits) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher; PerkinElmer; Illumina; Takara Bio; BASECARE; Jabrehoo
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options